This compound is primarily utilized in the field of medicinal chemistry as a key intermediate in the synthesis of various pharmaceutical agents. Its structure, featuring both a bromo and a fluoro substituent on the phenyl ring, along with a cyclopropyl group, makes it a valuable building block for designing molecules with potential biological activity. It is often employed in the development of compounds targeting central nervous system disorders, such as antidepressants, anxiolytics, or antipsychotics, due to its ability to interact with neurotransmitter receptors. Additionally, its unique chemical properties make it suitable for research in drug discovery, particularly in optimizing pharmacokinetic and pharmacodynamic profiles of lead compounds. The compound may also be explored in the creation of bioactive molecules for treating other conditions, including inflammation or infectious diseases, depending on its structural modifications.